Anatoly Peshko: TREATMENT CONCEPT …16.03.2021
Anatoly Peshko: TREATMENT CONCEPT …
A new entry by political scientist Anatoly Peshko has been published on the website of the main opposition project of Ukraine “Voice of Pravdy”:
The urgency of cancer treatment remains no less acute than it was 28 years ago, when I was forced to stop my research in this area in 1992. I managed to discover some fundamentally important things that make it possible to treat this disease without the use of chemotherapy and radiation therapy, but in a purely biological way.
What is the basic principle of such treatment based on:
Cancer is not a local disease of a particular organ, but as you know, it is a systemic disease that tends to be transmitted even genetically. This indicates the presence of a defect in the genetic apparatus of certain people, in whom the gene responsible for the growth and differentiation of a particular type of tissue has a weak physicochemical structure, where in the DNA strands responsible for the processes of reparation of growth and differentiation of cells embedded in each cell the human body from birth, there is such a set of carbon and hydrogen atoms when the amount of carbon bond in the DNA chain (C-C) is much more common than carbon-hydrogen bonds (C-H). As you know, purely carbonaceous bonds are less resistant to external adverse factors, say, viruses, various physical influences (trauma, ionizing radiation) and chemical influences (various toxic substances containing heavy metal salts, decay products of nitrogenous bases, etc.).
Thus, in the body of those people who have DNA strands and, in particular, a gene for growth and differentiation, as well as, in fact, possible tissue dedifferentiation, which can be compared depending on which feedback mechanism is turned off. That is, if the feedback mechanism that stops the growth of differentiated tissue is damaged under an unfavorable effect, then a benign tumor develops in any cell of any organ of the human body.
If the feedback mechanism is damaged in the direction of dedifferentiation of one or another cell of any type of tissue in the human body, then in this case, an oncological disease occurs (i.e., a tumor in which tissue growth and dedifferentiation is constantly occurring). It is noteworthy that the growth and division of dedifferentiated cells is practically unlimited in time, that is, the less differentiated the cells, the more their division and life are not limited. This is an important point for understanding that, in principle, this mechanism can be used to obtain protein materials, for example, to obtain protein in unlimited quantities, for example, to produce protein for feeding animals, and, possibly, in the future, for humans.
But in this case, we are looking at the main question of how you can overcome cancer. There are two ways to solve this problem: one is genetic. To do this, we need to find a locus in each cell of a particular type of tissue that is responsible for the above process of tissue growth and differentiation during the development of a person from an embryo, and this gene also works in physiological or post-traumatic repair of tissues and organs. Damage to the mechanism responsible for the growth and dedifferentiation of any type of tissue is the cause of oncological disease.
Why does damage to one or another mechanism responsible for the growth and differentiation or dedifferentiation of tissue cause the development of benign or malignant tumors? The reason is that during the work of a gene responsible for the growth of differentiation or dedifferentiation of tissues, genes of this type produce substances of a protein and non-protein nature, which block the immunological reaction by the formation of antibodies to those alien to the body of an ordinary person or a pregnant woman. in the body of which the fetus develops, almost all tissues and organs of which are in the process of growth and differentiation until the fetus is fully ripe. It is because of the active work of the genes for growth and differentiation, as well as tissue dedifferentiation, that the body of a person with a tumor or a pregnant woman releases practically similar substances of a protein and non-protein nature to tissues growing in the body of these people with a foreign antigenic structure.
Therefore, for the genetic treatment of any tumor diseases, both benign and malignant, it is necessary in the genetic structure of each type of tissue to find loci that are responsible for disinhibition of the feedback mechanism, i.e., trigger the feedback mechanism that inhibits both uncontrolled differentiation processes ( stopping benign growth) and inhibiting the processes of undifferentiated growth, i.e. stopping the growth of malignant tumors.This is the thesis outlined the principle of genetic treatment of oncopathologies.The second principle is the immunological principle of treatment of oncopathologies.
Considering the fact that the work of any growth gene, both differentiated and undifferentiated tissue, blocks the immune response to the antigenic structure of growing tissues in any organ of the human body, the process of stopping and destroying malignant tumors of any tissue that has an antigenic structure different from the antigenic structure of its host can be carried out by increasing immune cells in the body of a sick person, primarily killer and helper T-lymphocytes, which would be activated, and not blocked by protein and other substances that are produced by a functioning gene for the growth and differentiation of damaged (oncological) tissue.
To do this, there are two options for solving problems:
1. The simplest. To suppress the growth of cancer cells in the patient’s body, it is possible to transfuse him with fresh blood taken from the woman in labor in the first 2-8 hours after childbirth, respectively, the blood must correspond to the group, Rh of the cancer patient, and also have biological compatibility with his blood (tested in Vitro). at the same time, blood can be taken only from those women in labor who have no history of hereditary oncological diseases in the direct line of kinship. Transfusion of such blood in quantities that should correlate in proportion to the size, volume of tumor tissue, its histological type and stage of the disease. That is, the larger the volume of tumor tissues, the more aggressive histological form of the disease, the more advanced the stage of the disease, the more often and in large volumes it is necessary to carry out the above-described blood transfusion. This method of treatment is the most primitive and simple, but nevertheless, it can stop the growth and begin the destruction of malignant cells also through the transfusion of red blood cells contained in whole blood. It is a building material for the restoration of red blood of anemized cancer patients, as well as a biological stimulator of the immunological response of a cancer patient, in terms of stimulating T-cell immunity, and in terms of stimulating B-cell immunity, which usually eliminates the bacterial infections that accompany weakened cancer patients, especially after they underwent radiation and chemotherapy or surgery.
2. The second method of immunological treatment is much more expensive. Its principle is that T-lymphocytes, both T-helpers and T-killers, are extracted from the blood directly from a cancer patient in a ratio of approximately 2: 3. Then, using genetic engineering methods in the laboratory, by cloning, increase the above T-lymphocytes in an amount directly proportional to the size of the tumor, its histological structure and the severity of the disease (stage). That is, with the mildest, initial forms of the disease, 1-2 billion cells are enough, with the second stage – 3-4 billion cells, with the third stage – 4-5 billion cells, with the fourth stage – 5-6 billion cells. Again, the frequency of administration and the number of cells injected are directly proportional to the volume, histological structure, and stage of cancer. At the same time, with each introduction of cloned T-lymphocytes, they must be activated with substances of a humoral and other nature, which are precisely produced in the body of a pregnant woman, immediately before and during childbirth! These substances can be isolated from the blood of women in labor by separating the blood into fractions. Then, to determine the most appropriate blood fraction that has the strongest stimulating effect on artificially cloned T-lymphocytes, it is necessary to activate each dose of T-killers and T-helpers (in a ratio of 3: 2) for several hours before each administration of the corresponding dose of lymphocyte mass. into the bloodstream of a cancer patient.
For a more detailed and optimal isolation and study of substances from the blood of women in labor, which most optimally activate T and B-cell immunity, a further, more thorough study of the biological, biochemical and physical properties of those components contained in the blood of women in labor that activate a powerful immune response of the human body is necessary … This will allow in the future, already artificially synthesizing those substances of a protein nature that are capable of causing the activation of suppressed immune systems in patients suffering not only from cancer, but also in HIV-infected patients, as well as in patients infected with various severe viral diseases. This technique can have far-reaching positive therapeutic effects in therapy, not only oncological, but also other diseases associated with a weakened or blocked immune system in humans or animals. Also, this technique will undoubtedly be effective in the treatment of any influenza viruses, incl. , so relevant today coronavirus Covid-19.
First vice president
academy of economic
of Sciences of Ukraine, Academician,
Doctor of Economics
Sciences, Candidate of Medical
Sciences A. V. Peshko